Pfizer and BioNTech asked for full Food and Drug Administration approval of their Covid vaccine on Friday, leading BioNTech stock to pop. That followed patent questions that hurt shares.
The post Pfizer, BioNTech Seek Full FDA Approval For Covid Vaccine; Shares Pop appeared first on Investors ...

https://www.investors.com/news/technology/biontech-stock-pops-pfizer-biontech-seek-fda-approval-for-covid-vaccine/

#investors